345 related articles for article (PubMed ID: 12848754)
1. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit.
Zaragoza R; Artero A; Camarena JJ; Sancho S; González R; Nogueira JM
Clin Microbiol Infect; 2003 May; 9(5):412-8. PubMed ID: 12848754
[TBL] [Abstract][Full Text] [Related]
2. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.
Ibrahim EH; Sherman G; Ward S; Fraser VJ; Kollef MH
Chest; 2000 Jul; 118(1):146-55. PubMed ID: 10893372
[TBL] [Abstract][Full Text] [Related]
3. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.
Vallés J; Rello J; Ochagavía A; Garnacho J; Alcalá MA
Chest; 2003 May; 123(5):1615-24. PubMed ID: 12740282
[TBL] [Abstract][Full Text] [Related]
4. [Effect of adequate initial antimicrobial therapy on mortality in critical patients with Pseudomonas aeruginosa bacteremia].
González AL; Leal AL; Cortés JA; Sánchez R; Barrero LI; Castillo JS; Álvarez CA
Biomedica; 2014 Apr; 34 Suppl 1():58-66. PubMed ID: 24968037
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2005 Feb; 49(2):760-6. PubMed ID: 15673761
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy.
Schechner V; Gottesman T; Schwartz O; Korem M; Maor Y; Rahav G; Karplus R; Lazarovitch T; Braun E; Finkelstein R; Lachish T; Wiener-Well Y; Alon D; Chowers M; Bardenstein R; Zimhony O; Paz A; Potasman I; Giladi M; Schwaber MJ; Klarfeld-Lidji S; Hochman M; Marchaim D; Carmeli Y
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):38-45. PubMed ID: 21763093
[TBL] [Abstract][Full Text] [Related]
7. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology, antibiograms and predictors of mortality among critically-ill patients with central line-associated bloodstream infections.
Kuo SH; Lin WR; Lin JY; Huang CH; Jao YT; Yang PW; Tsai JR; Wang WH; Chen YH; Hung CT; Lu PL
J Microbiol Immunol Infect; 2018 Jun; 51(3):401-410. PubMed ID: 28943144
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes.
Sligl WI; Dragan T; Smith SW
Int J Infect Dis; 2015 Aug; 37():129-34. PubMed ID: 26159847
[TBL] [Abstract][Full Text] [Related]
10. Rate and pattern of antibiotic resistance in microbiological cultures of sepsis patients in a low-middle-income country's ICU.
Bataar O; Khuderchuluun C; Lundeg G; Chimeddorj S; Brunauer A; Gradwohl-Matis I; Duenser MW
Middle East J Anaesthesiol; 2013 Oct; 22(3):293-300. PubMed ID: 24649786
[TBL] [Abstract][Full Text] [Related]
11. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.
Garnacho-Montero J; Garcia-Garmendia JL; Barrero-Almodovar A; Jimenez-Jimenez FJ; Perez-Paredes C; Ortiz-Leyba C
Crit Care Med; 2003 Dec; 31(12):2742-51. PubMed ID: 14668610
[TBL] [Abstract][Full Text] [Related]
12. Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.
Tellor B; Skrupky LP; Symons W; High E; Micek ST; Mazuski JE
Surg Infect (Larchmt); 2015 Dec; 16(6):785-93. PubMed ID: 26258265
[TBL] [Abstract][Full Text] [Related]
13. [Risk and prognostic factors of Pseudomonas aeruginosa bacteremia in critically ill patients].
Alvarez-Lerma F; Pavesi M; Calizay M; Valles J; Palomar M;
Med Clin (Barc); 2001 Dec; 117(19):721-6. PubMed ID: 11737996
[TBL] [Abstract][Full Text] [Related]
14. The effect of duration of antimicrobial treatment for bacteremia in critically ill patients on in-hospital mortality - Retrospective double center analysis.
Zuercher P; Moser A; Frey MC; Pagani JL; Buetti N; Eggimann P; Daneman N; Fowler R; Que YA; Prazak J
J Crit Care; 2023 Apr; 74():154257. PubMed ID: 36696827
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
[TBL] [Abstract][Full Text] [Related]
16. 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial.
Daneman N; Rishu AH; Pinto R; Aslanian P; Bagshaw SM; Carignan A; Charbonney E; Coburn B; Cook DJ; Detsky ME; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Sligl W; Stelfox HT; Wilcox ME; Fowler RA;
Trials; 2018 Feb; 19(1):111. PubMed ID: 29452598
[TBL] [Abstract][Full Text] [Related]
17. Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
Adrie C; Garrouste-Orgeas M; Ibn Essaied W; Schwebel C; Darmon M; Mourvillier B; Ruckly S; Dumenil AS; Kallel H; Argaud L; Marcotte G; Barbier F; Laurent V; Goldgran-Toledano D; Clec'h C; Azoulay E; Souweine B; Timsit JF;
J Infect; 2017 Feb; 74(2):131-141. PubMed ID: 27838521
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.
Kim YJ; Jun YH; Kim YR; Park KG; Park YJ; Kang JY; Kim SI
BMC Infect Dis; 2014 Mar; 14():161. PubMed ID: 24655422
[TBL] [Abstract][Full Text] [Related]
19. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Macas A; Sakalauskas R
Medicina (Kaunas); 2010; 46(7):490-5. PubMed ID: 20966623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
